Music Therapy for Cancer Patients(Meraki_PC)
Launched by UNIVERSITY OF VALENCIA · Mar 28, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called Music Therapy for Cancer Patients (Meraki_PC), is exploring how music therapy can help improve the emotional well-being and quality of life for cancer patients who are receiving palliative care. Palliative care focuses on providing comfort and support for patients with serious illnesses. The study will look at how personalized music therapy sessions can help these patients cope better with their illness and enhance their psychological health.
To be eligible for this trial, patients need to be at least 18 years old, receiving palliative care for cancer, and have been admitted to the hospital recently. They should also have clear thinking abilities, meaning they are not facing moderate to severe cognitive challenges. Participants will take part in a few music therapy sessions and will have assessments before and after the treatment to see how it has helped them. This trial is currently recruiting, and it aims to provide valuable insights into the benefits of music therapy for those in advanced stages of cancer, offering them supportive care during a difficult time.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The patient is receiving palliative care for an oncological diagnosis and was admitted to the hospital a week ago. They do not have moderate to severe cognitive impairment. This treatment is for oncological patients in an advanced stage who are receiving palliative anti-tumour treatment such as chemotherapy and/or radiotherapy. These patients require support treatment that cannot be provided at home due to their complexity. The patient is in an advanced or terminal phase of the disease according to WHO criteria.
- • Be over 18 years of age.
- • Have preserved cognitive ability (SPMSQ, Pfeiffer). More than 2 errors (3 in illiterate persons) would suggest the presence of cognitive impairment.
- • Have signed the informed consent form
- • Have completed at least 2 of the 3 treatment sessions and have completed the pre-test and post-test assessment.
- Exclusion Criteria:
- • -Estimated survival time. Patients with a life expectancy of two weeks or less shall not be operated on.
About University Of Valencia
The University of Valencia, a prestigious institution located in Spain, is dedicated to advancing scientific knowledge and improving public health through innovative research. With a strong emphasis on interdisciplinary collaboration, the university engages in a wide array of clinical trials aimed at addressing pressing medical challenges. Its commitment to ethical standards and regulatory compliance ensures the integrity of its research initiatives, while its experienced team of researchers and clinicians work diligently to translate scientific discoveries into practical applications that benefit patients and communities. The University of Valencia is at the forefront of medical research, fostering a culture of excellence and innovation in the pursuit of better healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Serra, Valencia, Spain
Patients applied
Trial Officials
Marián Pérez Marín, PhD
Principal Investigator
University of Valencia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported